• Journal of Dairy Science and Biotechnology
• /
• 제26권2호
• /
• pp.45-49
• /
• 2008

We studied the feasibility of monitoring and controlling the manufacturing process of an infant formula with rice starch by testing in-process samples using rheology. We used DSC to first determine the gelatinization temperature of the rice starch, a key ingredient of this product. With this characteristic temperature and the process design known, rheological measurements were conducted on the in-process samples for detecting the presence and extent of gelatinization and retrogradation of rice starch; in-process samples were collected from the carbohydrate tank, after the homogenizer, and the finished product tank. The correlation between the rheological measurements on these samples and manufacturing performance proved that rheology is a very sensitive tool for monitoring the structural development of this infant formula during main process, and their influence on sterilization efficiency. We observed that the lower degree of gelatinization during main process, a shorter residence time in the finished product tank, and using caustic flush rather than clean-in-place additively lead to higher sterilization efficiency. These findings can be utilized for a rational design and analysis of the manufacturing process for infant formulas containing rice starch.

• 한국축산식품학회지
• /
• 제38권2호
• /
• pp.376-390
• /
• 2018

Cronobacter species have been associated with disease outbreaks and sporadic infections, particularly in premature and immunocompromised infants. Cronobacter species can cause foodborne infections such as neonatal meningitis, septicaemia and necrotising enterocolitis. Accordingly, there is an urgent need to control and monitor the Cronobacter species in food, especially in powdered infant formula (PIF) and other baby foods. Therefore, in this review, the isolation and prevalence of Cronobacter species in infant food including PIF and the recent advance of detection methods are discussed for the better understanding on the current research status of Cronobacter species.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제24권3호
• /
• pp.316-324
• /
• 2021

Purpose: The use of soy-based infant formula has increased widely in infants with cow's milk allergy (CMA). This study aimed to provide evidence on the growth pattern of CMA infants fed with soy-based infant formula in an Indonesian setting. Methods: A multi-site, intervention study was conducted among full-term and normal birth weight CMA infants. Within six months, the subjects were provided with a soy-based infant formula. Weight, height, and head circumference were measured at baseline, weeks 4, 8, 12, 16, 20, and 24. Adverse events were recorded by scoring atopic dermatitis and symptom-based clinical scores. Results: Based on the World Health Organization growth chart, we found that most of subjects had normal nutritional status for weight-for-age, length-for-age, weight-for-length, and head-circumference-for-age. There were statistically significant differences between baseline and end-line for weight-for-age, length-for-age, weight-for-length, and head circumference-for-age nutritional status. No allergic symptoms or intolerance toward soy formula were observed at the end of the intervention period. Conclusion: These results show that infants fed with soy-based infant formula have a normal pattern of growth.

• Clinical and Experimental Pediatrics
• /
• 제62권5호
• /
• pp.149-154
• /
• 2019

The World Health Organization recommends that infants should be exclusively breastfed for the first 6 months of life to provide optimal nutrition in this critical period of life. After this, infants should receive nutritionally adequate and safe complementary foods while breastfeeding continues for up to 2 years of age or beyond. For nonbreastfed infants, infant formula is an available option to provide the nutrition needed. Infant formula is usually prepared from industrially modified cow's milk and processed to adjust for the nutritional needs of infants. However, cow's milk is one of the most common causes of food allergy, affecting 2%-5% of all formula-fed infants during their first year of life. One strategy to prevent cow's milk allergy in nonbreastfed infants is the use of partially hydrolyzed formula (pHF) in high-risk infants, which are infants born in families with atopic disease. However, based on an epidemiological study, approximately half of the infants who develop allergy are not part of the at-risk group. This is because the non-at-risk group is significantly larger than the at-risk group and the non-at-risk infants have approximately 15% risk of developing allergies. This study aimed to evaluate the effects of partially hydrolyzed whey formula (pHF-W) in nonbreastfed infants and determine whether pHF-W can prevent atopic disease in high-risk infants and can be used as routine starter formula regardless of the allergy risk status.

• 한국생명과학회:학술대회논문집
• /
• 한국생명과학회 2007년도 제48회 학술심포지움 및 추계국제학술대회
• /
• pp.56.1-56.1
• /
• 2007

See Full Text

• 한국축산식품학회지
• /
• 제18권4호
• /
• pp.285-291
• /
• 1998

Adsorption isotherms of water vapour for infant formula milk powders manufactured by P. M. and N company in Korea were measured at temperatures between 20, 30 and 40$^{\circ}C$ using COST-90 modified method. Results showed that the isotherms were sigmoidal in shape. The adsorption isotherms of milk powder were depending on the temperature and products. The BET-model were applied and analyzed to compare the experimental value. It was found that the BET-model is fitted with measuring data. Sample P showed the lowest monolayer value and sample N showed the highest. Isosteric heat obtained upon application of BET-model was calculated in this field of temperature using the Clausius-Clapeyron equation. It is suggested that the usage of the BET-model to estimate the heat of water sorption in infant formula milk powder should be in agreement with the results from COST-90 project.

• 한국축산식품학회지
• /
• 제34권6호
• /
• pp.749-756
• /
• 2014

A rapid and simple analytical method for L-carnitine was developed for infant and toddler formulas by liquid chromatography tandem mass spectrometry (LC-MS/MS). A 0.3 g of infant formula and toddler formula sample was mixed in a 50 mL conical tube with 9 mL water and 1 mL 0.1 M hydrochloric acid (HCl) to chemical extraction. Then, chloroform was used for removing a lipid fraction. After centrifuged, L-carnitine was separated and quantified using LC-MS/MS with electrospray ionization (ESI) mode. The precursor ion for L-carnitine was m/z 162, and product ions were m/z 103 (quantitative) and m/z 85 (qualitative), respectively. The results for spiked recovery test were in the range of 93.18-95.64% and the result for certified reference material (SRM 1849a) was within the range of the certificated values. This method could be implemented in many laboratories that require time and labor saving.

• 한국식품영양과학회지
• /
• 제37권9호
• /
• pp.1214-1221
• /
• 2008

본 연구에서는 영 유아용 조제식의 안전성에 대한 소비자의 신뢰도를 회복하고 영 유아의 성장 및 발달에 도움이 되고자 우리나라, CODEX, EU, 호주 및 뉴질랜드의 영 유아용 조제식내 식품첨가물 및 오염물질 기준을 비교 분석하고 국내 영 유아용 조제식 기준의 문제점과 개선방안을 다음과 같이 제시하였다. 영 유아용 조제식내 식품첨가물 기준은 영양품질 개선을 목적으로 하는 영양 강화제와 식품에 첨가물 용도로 사용되는 식품첨가물로 분류하여 비교하였다. 영양 강화제의 경우 CODEX, EU, 호주 및 뉴질랜드에서는 영양소 유형에 따라 분류하여 제시한 반면, 우리나라에서는 영양 강화제의 명칭을 종합적으로 나열하여 제시하였다. 따라서 우리나라에서도 영양 강화제에 대하여 영양소별로 구분하여 제시할 필요성이 제기된다. 또한 첨가물 용도로 사용되는 식품첨가물의 경우 국내에서는 허용량이 규정되어 있지 않으므로 허용 식품첨가물의 명칭 및 최대 허용량을 제시하여 국제 기준과의 조화를 고려하도록 한다. 오염물질기준의 경우 국내에서는 일부 위해 미생물(E. sakazakii, B. cereus)과 방사선 조사처리 기준만 설정되어 있으나, CODEX 및 EU는 농약 기준을, 호주 및 뉴질랜드는 위해 미생물(Staphylococcus aureus, Salmonella sp.)과 중금속 중 납과 알루미늄의 최대 허용량에 대한 허용기준을 추가로 규정하고 있다. 따라서 우리나라 영 유아용 조제식의 안전성을 입증할 수 있는 과학적인 자료를 토대로 위해 미생물, 농약 및 기타 오염물질 기준을 정량적으로 추가 제시할 필요성이 제기된다.

• Journal of Nutrition and Health
• /
• 제30권5호
• /
• pp.478-488
• /
• 1997

Omega-3 fatty acid, docosahexaenoic acid(DHA) is found in a high proportion in the structural lipids of cell membranes, in particular those of the central nervous system and the retina. Diet-induced changes in fatty acid composition in these tissues may affect physiochemical functions. This study was conducted to investigate whether supplements of DHA in infant formula has an effect on the composition of fatty acids in erythrocytes with regard to brain development. Experimental groups were breastmilk group(n=21), placebo formula group(n=15), and DHA supplemented formula (0.26%) group(n=16). Infants were selected by mothers who deliverecdd at Kyung Hee medical center from February to April, 1996. Infant body weight, length, and head circumference were similar among the experimental groups at 16 weeks of age. The levels of DHA in breastmilk, placebo formula, and DHA supplemented formula were 0.56, 0, and 0.26% of total fatty acids, respectively. There was a significant correlation between dietary DHA intake and erythrocyte DHA levels. The levels of arachidonic acid did not differ among the three expermental groups. The result of flash visual evoke potential(VEP) test was correlated with the erythrocyte levels and dietary DHA levels at 16 weeks of age. No other fatty acid was correlated with VEP test results. No differences were found in Bayley Mental and Psychomotor Development Index scores among the three groups at 20 weeks of age. DHA seems to be an essential nutrient for optimum growth and maturation of term infants. Relatively small amounts of dietary DHA supplementation significantly elevate DHA supplementation significantly elevate DHA content in erythrocytes, which in turn has an implication for better scores for infant's VEP test. Whether supplementation of formula-fed infants with DHA has long-term benefits remains to be elucidated.

• 대한지역사회영양학회지
• /
• 제5권2호
• /
• pp.273-279
• /
• 2000

This study was carried out to evaluate the calcium and phosphorus intakes and correlation with growth performance of 25male breast and formula-fed infants from 1 to 3 months postpartum. There were four groups breast-fed(BF) and three formula-fed groups(FFM, FFN and FFP). There was no significant difference in the height and weight of infants according to feeding methods and formula brands. Milk intake and the concentration of calcium and phosphorus from human milk and the formulas were measured. The average calcium content of human milk was 26.6$\pm$4.1mg/dl and 13.5$\pm$2.0mg/dl, respectively. The average calcium intakes of the brest-fed and formula-fed infants were 205.5$\pm$29.3mg/day and the 460.5$\pm$70.6mg/day, respectively the average calcium intake of breast-fed infants was significantly lower than that of formula fed infant. The percent of RDA(41%) of breast-fed infants was lower than that(75.4%) of formula fed infant. The average phosphorus intake of the brest-fed and formula-fed infants were 105.1$\pm$20.1mg/day and 288.3$\pm$37.3mg/day, respectively. The precent of RDA(27%) for brest fed was significantly lower than that(75.4%) of formula fed. The Ca/P ratios were 2.1 in brest fed and 1.6 in formula fed infant. The average calcium and phosphorus intakes of the formula fed infants was higher than that of the brest-fed infants. This data suggests the calcium and phosphorus intakes form human milk sufficiently support the growth of infants. Therefore, the level of calcium and phosphorus recommended dietary allowances for infants should be reduced.